Dysthymia: Associated Costs, Treatment and Change Process

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-31

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study evaluates cost and effect of inpatient versus outpatient treatment of dysthymia, as well as investigates the processes through which psychotherapy works in treating dysthymia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Secondary Prevention of Depression Applying an Experimental Attentional Bias Modification Procedure

NCT02658682

Major Depression

COMPLETED NA

Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging

NCT01831440

Depressive Disorder

UNKNOWN NA

Increasing Cost-effectiveness of Inpatient Treatment of Affective Disorders

NCT00662428

Depressive Disorder

COMPLETED NA

Internet-delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder

NCT04864353

Cognitive Remediation Cognitive Impairment Major Depression in Remission

COMPLETED NA

Chronotherapy for Depressive Episodes

NCT05691647

Depressive Episode

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Inpatient treatment allows a more intensive treatment and allows the patient to be in a context where it is possible to focus on the processes in therapy with minimal interruption. Outpatient treatment is much less intensive but allows the treatment process to unfold in the context where the patient is experiencing the problems that brought them to therapy. It is not clear which of the contexts will be more effective in alleviating symptoms of dysthymia. Further, as dysthymia is a very costly disease for society it is of interest to know if the two treatments are cost-effective, and which one is the most cost effective.

A great paucity on dysthymia research ha left the psychotherapy field without an understanding of the processes through which dysthymia is changed. This study will investigate the change process through frequent assessments of common factors, psychological processes, symptoms, heart rate variability and cognitive attention bias.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Cost Benefit Analysis Psychotherapeutic Processes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Inpatient treatment

High intensity high dosage inpatient short-term psychodynamic psychotherapy

Group Type ACTIVE_COMPARATOR

Psychotherapy

Intervention Type BEHAVIORAL

Outpatient treatment

Low dosage outpatient short-term psychodynamic psychotherapy

Group Type EXPERIMENTAL

Psychotherapy

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Psychotherapy

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

* current suicidal risk, current psychosis, marked emotional instability (i.e. issues with impulsivity), strong paranoid traits, current problems related to heavy substance abuse.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No